Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 99

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 5
Chunk 99
---
 foreign exchange rates, was largely attributable to continued generic erosion of sales of VYVANSE (for attention deficit hyperactivity disorder (“ ADHD”)) in the U. S., which began following loss of exclusivity in August 2023. In addition, revenue outside of our six key business areas decreased mainly due to the decline in sales of AZILVA (for hypertension), which were JPY 11.8 billion (JPY -21.8 billion and -64.9% AER, -64.9% CER) following the entry of generic competitors in Japan beginning in June 2023.

Table of Contents

Revenue by Geographic Region

The following shows revenue by geographic region:

                                      Billion JPY or percentage                                                                        
                                      For the fiscal year ended                                             AER                   CER  
                                      March 31,                                                                                        
  Revenue:                                                                                                                             
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Japan                               ¥                                451.4          ¥        418.5          ¥      (7.3)      (7.4)  
  United States                                                      2,195.7                 2,379.7      183.9        8.4        2.5  
  Europe and Canada                   966.8                                                  1,055.3       88.4        9.1        4.1  
  Latin America                       198.1                                       235.8                    37.7       19.1       19.7  
  China                               174.8                                       191.7                    16.9        9.7        4.8  
  Asia (excluding Japan & China)      86.4                                         99.4                    13.0       15.1       11.6  
  Russia/CIS                          72.6                                         72.4                   (0.2)      (0.3)      (1.0)  
  Other (1)                           117.9                                       128.8                    10.9        9.3        4.7  
  Total                               ¥                              4,263.8                 4,581.6      317.8        7.5        2.9  

____________

Note:

(1) Other includes the Middle East, Oceania and Africa.

Revenue by Business Area

The following shows revenue by business